P
Pitcairn Portfolio holdings
AUM
$1.53B
This Quarter Return
+5.62%
1 Year Return
+21.82%
3 Year Return
+85.13%
5 Year Return
+134.47%
10 Year Return
+322.74%
AUM
$825M
AUM Growth
+$16.5M
(+2%)
Cap. Flow
-$24M
Cap. Flow
% of AUM
-2.9%
Top 10 Holdings %
Top 10 Hldgs %
51%
Holding
533
New
34
Increased
103
Reduced
338
Closed
47
Top Buys
| 1 |
iShares Russell 1000 Value ETF
IWD
|
$20.1M |
| 2 |
iShares Russell 3000 ETF
IWV
|
$2.38M |
| 3 |
Thermo Fisher Scientific
TMO
|
$1.97M |
| 4 |
Edwards Lifesciences
EW
|
$1.1M |
| 5 |
Synopsys
SNPS
|
$1.05M |
Top Sells
Sector Composition
| 1 | Consumer Staples | 24.08% |
| 2 | Financials | 10.11% |
| 3 | Technology | 8.94% |
| 4 | Healthcare | 6.67% |
| 5 | Consumer Discretionary | 5.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Travelers Companies
TRV
$62.3B
| $2.12M | 0.26% |
17,601
+2
| +0% | +$241 |
|
52
Northrop Grumman
NOC
$83.2B
| $2.1M | 0.25% |
8,806
-3,602
| -29% | -$857K |
|
53
AT&T
T
$208B
| $2.09M | 0.25% |
66,575
+2,111
| +3% | +$66.2K |
|
54
Corpay
CPAY
$22.6B
| $2.08M | 0.25% |
13,716
+751
| +6% | +$114K |
|
55
iShares MSCI EAFE ETF
EFA
$65.4B
| $2M | 0.24% |
32,102
| – | – |
|
56
Comcast
CMCSA
$125B
| $1.98M | 0.24% |
52,601
-3,733
| -7% | -$140K |
|
57
iShares Russell 2000 ETF
IWM
$66.6B
| $1.97M | 0.24% |
14,294
+248
| +2% | +$34.1K |
|
58
Pfizer
PFE
$141B
| $1.97M | 0.24% |
60,545
+2,755
| +5% | +$89.4K |
|
59
Akamai
AKAM
$11.1B
| $1.93M | 0.23% |
32,281
+383
| +1% | +$22.9K |
|
60
TE Connectivity
TEL
$60.9B
| $1.92M | 0.23% |
25,801
+2,119
| +9% | +$158K |
|
61
TripAdvisor
TRIP
$2B
| $1.92M | 0.23% |
44,452
+5,503
| +14% | +$237K |
|
62
Wabtec
WAB
$32.7B
| $1.88M | 0.23% |
24,043
-1,039
| -4% | -$81K |
|
63
Altria Group
MO
$112B
| $1.86M | 0.23% |
26,063
-4,884
| -16% | -$349K |
|
|
MJN
64
DELISTED
Mead Johnson Nutrition Company
MJN
| $1.85M | 0.22% |
20,763
-7,776
| -27% | -$693K |
|
65
Cognizant
CTSH
$35.1B
| $1.81M | 0.22% |
30,405
-13,802
| -31% | -$822K |
|
66
Procter & Gamble
PG
$370B
| $1.79M | 0.22% |
19,921
+264
| +1% | +$23.7K |
|
|
67
Edwards Lifesciences
EW
$47.7B
| $1.77M | 0.21% |
56,322
+35,229
| +167% | +$1.1M |
|
68
Chevron
CVX
$318B
| $1.76M | 0.21% |
16,410
+658
| +4% | +$70.7K |
|
69
Genpact
G
$7.88B
| $1.72M | 0.21% |
69,302
-1,107
| -2% | -$27.4K |
|
70
Amgen
AMGN
$153B
| $1.62M | 0.2% |
9,899
+2,129
| +27% | +$349K |
|
71
US Bancorp
USB
$75.5B
| $1.61M | 0.2% |
31,319
+2,332
| +8% | +$120K |
|
72
Coca-Cola
KO
$297B
| $1.6M | 0.19% |
37,777
-1,124
| -3% | -$47.7K |
|
73
Philip Morris
PM
$254B
| $1.58M | 0.19% |
14,014
-145
| -1% | -$16.4K |
|
74
RTX Corp
RTX
$212B
| $1.57M | 0.19% |
22,235
-1,428
| -6% | -$101K |
|
75
Merck
MRK
$210B
| $1.56M | 0.19% |
25,650
+687
| +3% | +$41.6K |
|